This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Støving, R. K. Articles by Frystyk, J. Search for Related Content PubMed PubMed Citation Articles by Støving, R. K. Articles by Frystyk, J. Related Collections Neuroendocrinology and Pituitary

Bioactive Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein-1 in Anorexia Nervosa

Center for Eating Disorders and Department of Endocrinology (R.K.S., D.G., K.B., K.H.), Odense University Hospital, DK-5000 Odense, Denmark; and Medical Research Laboratories (J.-W.C., A.F., J.F.), Clinical Institute, Aarhus University Hospital, DK-8000 Aarhus C, Denmark

Address all correspondence and requests for reprints to: René Klinkby Støving, Department of Endocrinology M, Odense University Hospital, DK-5000 Odense, Denmark. E-mail: rene.k.stoving{at}dadlnet.dk.

Context: Regulation of IGF-I activity appears crucial in anorexia nervosa (AN) during adaptation to chronic starvation as well as during the regenerative processes on nutritional restoration.

Objective: The objective of this study was to examine the relationship between IGF-I bioactivity and IGF-binding capacity as expressed as formation of the binary complex of IGF-binding protein-1 (IGFBP-1) and IGF-I in patients with AN at different stages and with different subtypes of the disease.

Design: This was a longitudinal study.

Setting: The study took place at a clinical research center at a university hospital.

Study Participants: We studied a total of 45 women with AN and 24 age-comparable healthy controls.

Main Outcome Measures: IGF-I bioactivity was determined using an IGF-I receptor activation assay, and IGF-I/IGFBP-1 complex formation was determined by an assay that allows direct determination of the binary complex.

Results: IGF-I bioactivity was significantly decreased in serum from patients with AN. We found significant correlations between total, ultrafiltered free, and bioactive IGF-I. Despite increased IGFBP-1 concentrations, levels of IGF-I/IGFBP-1 binary complex were not significantly increased in AN. Oral contraceptives were associated with increased levels of IGF-I, IGFBP-1, and binary complex formation. Ghrelin levels were only significantly raised in those patients who had lost more than 5% of the body weight during the last 4 wk, whereas ghrelin levels in weight-stable as well as in weight-gaining patients did not significantly differ from the controls.

Conclusions: Total IGF-I level is a suitable marker of IGF-I bioactivity in emaciated patients with AN irrespective of the clinical subtype and acute nutritional state.

This article has been cited by other articles:

				A. Rickenlund, M. Thoren, A. Nybacka, J. Frystyk, and A. Linden Hirschberg Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance Hum. Reprod., October 19, 2009; (2009) dep350v1. [Abstract] [Full Text] [PDF]

				A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF]

				M. P. Brugts, A. W. van den Beld, L. J. Hofland, K. van der Wansem, P. M. van Koetsveld, J. Frystyk, S. W. J. Lamberts, and J. A. M. J. L. Janssen Low Circulating Insulin-Like Growth Factor I Bioactivity in Elderly Men Is Associated with Increased Mortality J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2515 - 2522. [Abstract] [Full Text] [PDF]